Shurui

Chronology

Posted Sep 2025

Updated Jun 19, 2026

---

CE Mark (under MDR EU2017/745) for Urology, General Surgery, Gynaecology and Thoracic Surgery (adult and pediatric). Aug 28, 2025.

Shurui approved for expanded use in urological, gynecological, general and thoracic surgeries. 2025.

Shurui approved to single-port surgery of multiple surgical specialties. 2024.

Beijing Surgerii Robotics Co., Ltd received the Series C+ investment; Shurui single-port surgical robot
cleared by NMPA. 2023.

Beijing Surgerii Robotics Co., Ltd received the Series C investment. 2022.

Randomized controlled multi-institutional clinical trial on single-port robotic urological surgery. 2022.

Beijing Surgerii Robotics Co., Ltd received the Series B investment，and the Series B+ investment from Medtronic. 2021.

First single-port surgical robot that has passed the
special examination procedure of innovative medical devices in China. 2020.

Beijing Surgerii Robotics Co., Ltd received the angel round investment with the headquarter in Beijing and an innovation center in Shanghai. 2017.

Tech transfer (Dr. Kai Xu) so as to use Beijing Surgerii Robotics Co., Ltd to commercialize a newer generation of laparoscopic surgical robots. 2016.

The Shurui surgical robot, developed by Beijing Surgerii Robotics Company Limited, represents a new generation of single-port minimally invasive surgery.

Key Features

• The SHURUI system is the world’s first approved single-port surgical robot equipped with snake-like instruments, designed for dexterous manipulation and coordinated movement through a single 2.5 cm port.
• Its signature “dual continuum mechanism” incorporates dozens of flexible superelastic nitinol rods, offering superior load capacity, wide range of motion, and high reliability during complex procedures.
• The robotic system enables surgeons to operate up to three instruments and one endoscope simultaneously, allowing 360° access to the operative field while preventing external collisions.

Clinical Applications

• Shurui is approved for urological, gynecological, general, thoracic, and pediatric surgery, with first-in-world clinical cases for single-port robotic gastrectomy, prostatectomy, nephrectomy, and bronchial sleeve lobectomy.
• The system’s architecture enables highly flexible adoption of single-port, multi-port, and hybrid-port configurations depending on clinical need, with modular patient-side carts and exchangeable instruments.
• Particularly suited for microsurgery and pediatric procedures, it provides minimal scarring and recovery time while fulfilling the functional demands of multi-port laparoscopy through a single incision.

Technology and Company Background

• Shurui robots feature advanced teleoperation control algorithms, 3D vision display, image-guided navigation, and patented continuum robotic arm technology based on 20 years of research and more than 800 patents filed.
• Beijing Surgerii Robotics is a high-tech medical device enterprise headquartered in Beijing, China, with global patent coverage, clinical centers, and a robust trajectory of investment and innovation.

Links

Premios Medicina Siglo XXI (2024).

Technology overview: nitinol-based continuum mechanics.

The SHURUI® Single-Port Surgical Robot Receives its CE Certification

References

Wu Z, Wang Z, Moschovas MC, Bertolo R, Campi R, Rivas JG, Wei Y, Xia D, Xu B, Zhu Q, Teoh JY, Gandaglia G, Amparore D, Porpiglia F, Patel V, Wang L. Robot-assisted Single-port Radical Prostatectomy with the SHURUI SP and da Vinci SP Platforms: Comparison of the Technology, Intraoperative Performance, and Outcomes. Eur Urol Open Sci. 2024 Jul 17;67:26-37. doi: 10.1016/j.euros.2024.07.107. PMID: 39113717; PMCID: PMC11304864.

---

Locations

Headquater. Room 106, Building 2, Tiandi
Linfeng, Yongtaizhuang North Road,
Haidian District, Beijing

Research Centre. Building 23, 1500 Duhui Road,
Minhang District, Shanghai

---

Contact

Website: en.surgerii.com.cn
Email: service@surgerii.com
Phone：400-601-0277

Prior to commencing my venture into robotic surgery, I had established a firm grounding as an oncologic surgeon. My experience encompassed a wide range of resection and reconstructive procedures, as well as proficiency in minimally invasive surgical techniques and endoscopic surgery. These acquired skills and expertise serve as fundamental pillars for achieving success in robotic surgery.

---

Disclaimer and Accuracy Statement

All medical information provided on headneckroboticsurgery.com is uploaded and reviewed by a qualified medical doctor with the utmost care and in good faith. The content is accurate, up-to-date, and intended to offer valuable insights for both health professionals and patients. Specific update dates are noted to ensure transparency and relevance.

If you come across any information that you believe to be inaccurate or outdated, please do not hesitate to contact us directly. We are committed to maintaining the highest standards of accuracy and promptly addressing any concerns.